Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable recta cancer
โ Scribed by Bruce D. Minsky; Alfred M. Cohen; Nancy Kemeny; Warren E. Enker; David P. Kelsen; Gary Schwartz; Leonard Saltz; James Dougherty; Joanne Frankel; Jill Wiseberg
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 913 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background. The encouraging results seen in patients who received postoperative combined modality therapy in the adjuvant setting have prompted increased interest in preoperative combined modality therapy for patients with unresectable rectal cancer. The authors report the local control and survival
Twenty patients with primary or recurrent unresectable rectal cancer limited to the pelvis were entered on a Phase I trial of preoperative pelvic radiation therapy (RT) (5040 cGy) and two cycles of combined high-dose leucovorin (LV) and 5fluorouracil (S-FU), followed by surgery and ten cycles of pos
We present an analysis of acute toxicity of 3 cycles of neoadjuvant bolus methotrexate (MTX) with leucovorin (LV) rescue plus bolus 5-FU, followed by continuous infusion 5-FU with concurrent pre-operative 5040 cGy, and post-operative bolus 5-FU/ LV in patients with rectal cancer. Nine patients (1: u